WLWanlin Lai

Wanlin Lai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wanlin Lai has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    血浆磷酸化-tau217等生物标志物对四川德阳地区人群认知功能障碍的诊断价值

    by 婉琳 赖, 逸林 夏, 宇童 傅, 子介 黄, 超 杨, 越 王, 德波 李, 蕾 陈

    阿尔茨海默病(Alzheimer disease, AD)是一个连续的疾病谱,有症状的阶段包括轻度认知障碍(mild cognitive impairment, MCI)时期、痴呆时期(又称AD痴呆)。本研究聚焦于MCI和AD痴呆的筛查,即AD疾病谱的筛查,分析血浆生物标志物对四川德阳地区人群认知功能障碍的诊断价值,为认知功能障碍的早筛早诊提供证据。 2023年8–10月对四川德阳地区50岁及以上人群进行问卷调查。调查内容包括人口学信息、病史信息、认知功能评估。将MCI患者纳入MCI组,将AD痴呆患者纳入AD组,其余为健康对照(healthy controls, HC)组。对部分抽样(所有AD痴呆患者、随机抽样的MCI患者及HC)采用我国自主研发的超灵敏数字免疫芯片技术检测血浆磷酸化-tau217(phosphorylated tau217, p-tau217)等4种认知相关生物标志物,采用淀粉样蛋白-β(amyloid beta, Aβ)分子探针的正电子发射断层显像(positron emission tomography, PET)检测受试者(所有AD患者及部分MCI患者)的Aβ沉积情况,评估上述血浆生物标志物对认知功能障碍的诊断价值。 本研究共调查受试者2833人,其中AD痴呆患者30人(1.1%),MCI患者437人(15.4%),HC 2366人(83.5%)。对30名AD痴呆患者、50名MCI患者、35名HC进行了4种血浆生物标志物检测。其中,血浆p-tau217区分AD痴呆与HC、AD痴呆与MCI的效果最好,受试者操作特征曲线下面积(area under the curve, AUC)分别为0.96〔95%置信区间(confidence interval, CI)0.91~1.00〕和0.93(95%CI 0.87~0.98)。AD痴呆、MCI、HC三组血浆p-tau217水平分别为(2.32±1.27) pg/mL、(0.54±0.45) pg/mL、(0.42±0.19) pg/mL,差异有统计学意义(PPr>0.70,P<0.0001)。 采用国产自主研发技术检测血浆标志物能较好地诊断AD痴呆,尤其是血浆p-tau217诊断价值最高,或可推广用于人群的AD痴呆筛查。


  • Open Access

    Semiology Extraction and Machine Learning–Based Classification of Electronic Health Records for Patients With Epilepsy: Retrospective Analysis

    by Yilin Xia, Mengqiao He, Sijia Basang, Leihao Sha, Zijie Huang, Ling Jin, Yifei Duan, Yusha Tang, Hua Li, Wanlin Lai, et al.

    Background: Obtaining and describing semiology efficiently and classifying seizure types correctly are crucial for the diagnosis and treatment of epilepsy. Nevertheless, there exists an inadequacy in related informatics resources and decision support tools. Objective: We developed a symptom entity extraction tool and an epilepsy semiology ontology (ESO) and used machine learning to achieve an automated binary classification of epilepsy in this study. Methods: Using present history data of electronic health records from the Southwest Epilepsy Center in China, we constructed an ESO and a symptom-entity extraction tool to extract seizure duration, seizure symptoms, and seizure frequency from the unstructured text by combining manual annotation with natural language processing techniques. In addition, we achieved automatic classification of patients in the study cohort with high accuracy based on the extracted seizure feature data using multiple machine learning methods. Results: Data included present history from 10,925 cases between 2010 and 2020. Six annotators labeled a total of 2500 texts to obtain 5844 words of semiology and construct an ESO with 702 terms. Based on the ontology, the extraction tool achieved an accuracy rate of 85% in symptom extraction. Furthermore, we trained a stacking ensemble learning model combining XGBoost and random forest with an F1-score of 75.03%. The random forest model had the highest area under the curve (0.985). Conclusions: This work demonstrated the feasibility of natural language processing–assisted structural extraction of epilepsy medical record texts and downstream tasks, providing open ontology resources for subsequent related work.

  • Open Access

    Differentiation of epilepsy and psychogenic nonepileptic events based on body fluid characteristics

    by Yilin Xia, Wanlin Lai, Shihai Li, Zhining Wen, Lei Chen

    ObjectiveDifferential diagnosis between epileptic seizures and psychogenic nonepileptic events (PNEEs) is a worldwide problem for neurologists. The present study aims to identify important characteristics from body fluid tests and develop diagnostic models based on them. MethodsThis is a register-based observational study in patients with a diagnosis of epilepsy or PNEEs at West China Hospital of Sichuan University. Data from body fluid tests between 2009 and 2019 were used as a training set. We constructed models with a random forest approach in eight training subsets divided by sex and categories of tests, including electrolyte, blood cell, metabolism, and urine tests. Then, we collected data prospectively from patients between 2020 and 2022 to validate our models and calculated the relative importance of characteristics in robust models. Selected characteristics were finally analyzed with multiple logistic regression to establish nomograms. ResultsA total of 388 patients, including 218 with epilepsy and 170 with PNEEs, were studied. The AUROCs of random forest models of electrolyte and urine tests in the validation phase achieved 80.0% and 79.0%, respectively. Carbon dioxide combining power, anion gap, potassium, calcium, and chlorine in electrolyte tests and specific gravity, pH, and conductivity in urine tests were selected for the logistic regression analysis. C (ROC) of the electrolyte and urine diagnostic nomograms achieved 0.79 and 0.85, respectively. SignificanceThe application of routine indicators of serum and urine may help in the more accurate identification of epileptic and PNEEs.


  • Identifying risk factors for polycystic ovary syndrome in women with epilepsy: A comprehensive analysis of 248 patients

    by Wanlin Lai, Ning Shen, Huili Zhu, Shixu He, Ximeng Yang, Qi Lai, Rui Li, Shuming Ji, Lei Chen

    To assess the risk factors for polycystic ovary syndrome (PCOS) in women with epilepsy (WWE) and develop a practical approach for PCOS screening based on clinical characteristic, blood indicator, and anti‐seizure medication (ASM) profiles. This cross‐sectional study was conducted with 248 WWE who were consecutively enrolled from the Epilepsy Center of West China Hospital between April 2021 and March 2022. The epilepsy characteristics, blood indicators, and use of ASMs were compared between WWE with and without PCOS. Multivariate logistic regression was used to identify the factors independently associated with PCOS. The differential analysis showed that younger age at onset of epilepsy (2), use of levetiracetam (LEV) (≥1 year), higher levels of cholesterol, luteinizing hormone (LH) and anti‐Müllerian hormone (AMH), and lower levels of sex hormone‐binding globulin were associated with PCOS (p < .05). Multivariate logistic regression identified that obesity (BMI ≥25 kg/m2), use of LEV (≥1 year), and higher levels of AMH and LH were independently associated with PCOS in WWE (p < .05). Obesity (BMI ≥25 kg/m2), LEV use (≥1 year), and elevated AMH and LH levels suggest an increased in the probability of occurrence of PCOS in WWE. The combination of these profiles provides a practical approach for screening PCOS in WWE.


  • [Successful prediction and the process of the weaning of veno-arterial extracorporeal membrane oxygenation].

    by F Li, W Lai, Y Kang

    The weaning of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is one of the clinical challenges, and hospitals have developed experience-based strategies, so there is still a lack of unified standards and procedures for weaning. This paper discusses this issue from the definition of weaning success, evaluation of patients before weaning, predictive indicators, weaning process, etc. Summarizing research progress and problems so that providing guidance for the development of ECMO in the future, such as perfecting weaning process and putting forward scoring system to predict weaning success and clinical outcome.

  • A Two-Layer Ensemble Method for Detecting Epileptic Seizures Using a Self-Annotation Bracelet With Motor Sensors

    by Chunjiao Dong, Tianchun Ye, Xi Long, Ronald M. Aarts, Johannes P. van Dijk, Chunheng Shang, Xiwen Liao, Wei Chen, Wanlin Lai, Lei Chen, et al.

    Using monitoring devices could help avoid injuries and even death. Currently, wearable sensors such as motion sensors and other sensors are used to detect when the patient is having a seizure and alarm their caregivers. However, the development phase of these devices requires labor-intensive work on labeling the collected data, resulting in difficulties in developing wearable monitoring devices. Thus, a more automated auxiliary method of labeling seizure data and a wearable device to detect seizures for daily monitoring use are necessary. We collected data from epileptics outside the hospital with our proposed bracelet. The subjects were asked to press the mark button after they had seizures. We also presented an automatically extraction and annotation of moving segments (EAMS) algorithm to exclude nonmoving segments. Then, we used a two-layer ensemble model (TLEM) using machine learning methods to classify seizures and non-seizure moving segments, which was designed to deal with imbalanced dataset. Then, we build two individual TLEM models separately for the overall (all day and night) seizure detection case and the night seizure detection case, owing to different imbalance of these datasets. The EAMS algorithm exclude 93.9% raw inactive data. The TLEM model achieved 76.84% sensitivity (SEN) and 97.28% accuracy (ACU) for the overall case and achieved 94.57% SEN and 91.37% ACU for the night case. These results indicate that this bracelet can capture seizures efficiently, and our proposed TLEM has higher SEN and ACU than single-layer machine learning models.


  • Open Access

    Managing reproductive problems in women with epilepsy of childbearing age

    by Wanlin Lai, Shixu He, Dong Zhou, Lei Chen

    Girls and women constitute nearly 50% of all epilepsy cases. Apart from the disease symptoms, epilepsy and antiseizure medications (ASMs) may also affect the reproductive function, pregnancy and even the health of their offspring. Therefore, it is very important to identify and summarize the problems and risks for women with epilepsy (WWE) of childbearing age, and offer internationally recognized methods through multidisciplinary collaboration. In this review, we summarize the reproduction-related problems with WWE and propose multidisciplinary management by epileptologists, gynecologists and obstetricians, as well as other experts, from preconception to delivery. Large, multicenter registries are needed to advance our knowledge on new ASMs and their effects on WWE and their offspring.